Chamber and committees

I refer the member to the answer to question S6W-10433 on 20 September 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

The Scottish Stroke Improvement Programme report, published on 28 June, includes data from the Scottish Stroke Care Audit (SSCA). The SSCA measures quality of care of stroke services in each acute hospital, grouped by NHS board against the Scottish Stroke Care Standards.

The following table provides a breakdown of the core activity undertaken at the National Eye Centre at NHS Golden Jubilee, by month, since it opened in November 2020 up to the end of June 2022.

This does not include activity undertaken in main theatres at the NHS Golden Jubilee University National Hospital in 2020-21 prior to the National Eye Centre opening, nor any activity carried out in the National Eye Centre as part of the current independent sector contracts.

The Scottish Medicines Consortium (SMC) is a partner in a UK-wide multi-agency RAPID C-19 initiative, which is a collaborative partnership between the SMC and the National Institute for Health and Care Excellence (NICE). Building on this work, the SMC is exploring the potential for collaboration with NICE on a single technology assessment (STA) of tixagevimab–cilgavimab (Evusheld ® ) for the prevention of COVID-19.

As part of the Scottish Medicines Consortium’s (SMC) continuing role in the UK-wide multi-agency RAPID C-19 initiative, the collaborative partnership between the SMC and the National Institute for Health and Care Excellence (NICE) will extend to the multiple technology assessment (MTA) of the range of therapeutics for the treatment of COVID-19; therefore, a separate assessment of these medicines by the SMC will not be required.

The Scottish Government is committed to the recruitment of a minimum of 1,500 additional staff to support the operation of Scotland’s National Treatment Centres (NTCs) and is supporting a range of activity to achieve this.

The recruitment data we collate is management information and not suitable for publication. NTC Recruitment is the responsibility of each NHS Board. It is therefore for NHS Golden Jubilee to provide detail regarding their recruitment.

Following the publication of the National Advisory Committee for Stroke’s Progressive Stroke Pathway, work is underway to develop a refreshed Stroke Improvement Plan by the end of 2022. This will outline how recommendations in the Progressive Stroke Pathway will be prioritized and implemented, as well as a continued emphasis on the importance of the Scottish Stroke Care Standards.

The Scottish Stroke Care Standards are regularly reviewed in line with current evidence and updated guidelines. We monitor the implementation of these standards through the Scottish Stroke Care Audit to ensure that stroke patients in Scotland are receiving high quality care.

All beavers that have been captured in Tayside and translocated to projects in Scotland, England and Wales are subject to disease screening and appropriate treatment as a licence condition prior to release. This screening ensures that beavers released under licence from NatureScot are not carrying Giardia prior to any translocations.

The Stroke Improvement Plan has been in place since its introduction in 2014 and has provided the framework for the provision of stroke care in Scotland.

The Stroke Improvement Plan emphasises the importance of the delivery of the stroke bundle, to ensure that all appropriate patients receive timely access to key interventions. The latest Scottish Stroke Improvement Programme annual report (published in June 2022 and available at: https://www.publichealthscotland.scot/publications/scottish-stroke-improvement-programme/scottish-stroke-improvement-programme-2022-national-report/ ) contains data collected in 2021. This demonstrated improvements in the initiation of aspirin therapy within one day (92% in 2021 v. 89% in 2020) and stroke patients receiving brain imaging within 12 hours (89% in 2021 v. 86% in 2020). Stroke bundle performance data for 2022 will be available in the 2023 national report, due to be published in June 2023.

In line with the Stroke Improvement Plan’s priority relating to the need for a skilled and knowledgeable workforce, in 2022 the Scottish Government has continued to support Stroke and TIA Assessment Training (STAT+), a standardised programme of thrombectomy education for trained healthcare professionals. We have provided funding to enable Chest Heart and Stroke Scotland to continue to deliver these education sessions to NHS Boards across Scotland to ensure increased knowledge, skills and management of thrombectomy patients. The delivery of this education package will support the ongoing rollout of a national thrombectomy service.

Despite the continued and unprecedented challenges presented by the COVID-19 pandemic, the Scottish Stroke Improvement Programme report, published on 28 June, highlights areas where a high level of care is provided for stroke patients, including improvements in the number of patients who receive brain imagining within 12 hours of arrival to hospital.

We recognise that there are areas within stroke care that have proven particularly challenging and we are committed to continued improvement. We expect health boards to identify aspects of their stroke services which do not meet the Scottish Standards and to work to improve standards of care locally.